	Capitaux D'Emprunt		Date
Acadia Pharmaceuticals	USD 0	0	2025-03
Akebia Therapeutics	USD 47.64M	579K	2025-09
ALKERMES	USD 285.82M	639K	2024-09
Alnylam Pharmaceuticals	USD 2.48B	1.44B	2025-12
ANI Pharmaceuticals	USD 297.68M	310.67M	2025-09
BioMarin Pharmaceutical	USD 596.66M	501K	2025-09
Coherus Biosciences	USD 294.85M	2.33M	2025-03
Emergent BioSolutions	USD 446.5M	1.7M	2023-12
Exact Sciences	USD 2.33B	9.34M	2025-09
Glaxosmithkline	GBP 20.02B	4.72B	2025-09
Heron Therapeutics	USD 149.65M	157K	2024-09
Ionis Pharmaceuticals	USD 28.78M	596.71M	2025-09
Ironwood Pharmaceuticals	USD 583.99M	14.83M	2024-12
Lexicon Pharmaceuticals	USD 56.11M	2.54M	2025-06
Lonza	CHF 4.24B	602M	2024-12
Merck	USD 39.97B	6B	2025-09
Moderna	USD 610M	584M	2025-12
Myriad Genetics	USD 119.5M	60.2M	2025-09
Nektar Therapeutics	USD 107.51M	10.35M	2024-06
Neurocrine Biosciences	USD 169.5M	500K	2023-03
Pacira	USD 376.72M	1.37M	2025-09
Pfizer	USD 57.41B	93M	2025-09
PTC Therapeutics	USD 1.84B	298.68M	2025-09
Sanofi	EUR 15.72B	2.45B	2025-12
Sarepta Therapeutics	USD 1.04B	104.31M	2025-09
United Therapeutics	USD 100M	100M	2024-06
Vanda Pharmaceuticals	USD 3.15M	3.15M	2024-12
Xoma	USD 94.38M	7.82M	2025-09

Emergent BioSolutions Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.